Table 4

Predictors of mortality at 1 year post-TAVI in patients with a logEuroSCORE <20%

	Univariate OR (95% CI)	P value	Multivariate OR (95% CI)*	P value
Age (years)	1.001 (0.965 to 1.038)	0.947	0.996 (0.950 to 1.044)	0.868
Female gender	1.176 (0.726 to 1.905)	0.509	1.482 (0.842 to 2.609)	0.172
Cardiac history
Prior MI	1.028 (0.488 to 2.165)	0.942	0.854 (0.360 to 2.024)	0.720
Prior cardiac surgery†	0.802 (0.397 to 1.620)	0.539	0.772 (0.337 to 1.771)	0.542
Prior stroke	0.814 (0.312 to 2.123)	0.674	0.745 (0.248 to 2.236)	0.600
Comorbidities
AF	1.716 (1.065 to 2.766)	0.027	1.620 (0.947 to 2.770)	0.078
Hypertension	1.991 (0.601 to 6.595)	0.260	1.360 (0.389 to 4.761)	0.630
CAD	1.815 (1.112 to 2.961)	0.017	2.408 (1.361 to 4.262)	0.003
Mitral valve insufficiency (>II°)	1.757 (0.485 to 6.367)	0.391	1.636 (0.403 to 6.638)	0.491
Porcelain aorta	1.263 (0.752 to 2.121)	0.377	1.115 (0.638 to 1.950)	0.702
Pulmonary hypertension	1.628 (0.905 to 2.928)	0.104	1.527 (0.797 to 2.926)	0.202
COPD	1.169 (0.648 to 2.110)	0.605	1.154 (0.605 to 2.202)	0.664
Diabetes mellitus	1.166 (0.692 to 1.964)	0.564	0.966 (0.539 to 1.733)	0.908
Kidney insufficiency	1.156 (0.721 to 1.854)	0.546	0.983 (0.580 to 1.667)	0.949
NYHA class III or IV	1.716 (0.853 to 3.453)	0.130	1.519 (0.732 to 3.152)	0.262
LVEF (%)	0.990 (0.969 to 1.011)	0.346	0.988 (0.964 to 1.013)	0.352
Peak AV gradient (mm Hg)	1.002 (0.992 to 1.012)	0.747	0.999 (0.978 to 1.021)	0.931
Mean AV gradient (mm Hg)	1.003 (0.988 to 1.018)	0.668	1.012 (0.981 to 1.045)	0.446

*Adjusted for all other variables.
†Not including percutaneous coronary intervention.
AF, atrial fibrillation; COPD, chronic obstructive pulmonary disease; LVEF, left ventricular ejection fraction; MI, myocardial infarction; NYHA, New York Heart Association; STS, Society of Thoracic Surgeons; TA, transapical; TF, transfemoral.